Lipum AB (publ)
556813-5999InactiveDeveloping first-in-class antibody drug candidate for chronic inflammatory diseases.
Oversigt
- 5–9
- Medarbejdere
- 750–999t SEK
- Omsætning
- 2010
- Grundlagt
Nøglebeslutningstagere
Ola Sandborgh
CEO
Beskrivelse
Lipum AB (publ) is a clinical-phase biopharmaceutical company focused on developing novel treatments for chronic inflammatory diseases. Their lead drug candidate is SOL-116, a humanized monoclonal antibody designed to offer a unique mechanism of action. SOL-116 targets the Bile Salt-Stimulated Lipas...
Tags
Nøgleord
Virksomhedsoplysninger
- Branche
- Annan naturvetenskaplig och teknisk forskning och utveckling
- Juridisk form
- Aktiebolag
- Momsnummer
- SE556813599901
Beslutningstagere
1 kontakter i FunnelfeedrOla Sandborgh
CEO
Lignende virksomheder
20 lignende virksomheder i FunnelfeedrLipigon Pharmaceuticals AB
5–9 medarbejdereClinical-stage company developing novel drugs for lipid disorders.
SynAct Pharma AB
5–9 medarbejdereClinical-stage biotech resolving inflammation via novel oral therapies.
CANTARGIA AB
20–49 medarbejdereDeveloping antibody-based drugs targeting IL1RAP for serious diseases.
AQILION AB
5–9 medarbejdereDeveloping innovative treatments for chronic inflammatory diseases via early-stage partnering.
Transient Pharma AB
0 medarbejdereDeveloping peptide drugs targeting severe inflammatory diseases using natural templates.
Udforsk mere
Spørgsmål om Lipum AB (publ)
Vil du se Funnelfeedr i aktion?
Book en gratis demo og opdag, hvordan Funnelfeedr hjælper dig med at finde og konvertere dine ideelle kunder.
Book en demo